Round one of the the US CRISPR patent battle is over – but what does the PTABS’s no interference-in-fact decision … – JD Supra (press release)
|
Round one of the the US CRISPR patent battle is over – but what does the PTABS's no interference-in-fact decision …
JD Supra (press release) 3 Cpf1 is a new type of Cas protein (Class 2 type V) which is able to be used in CRISPR-mediated gene editing in place of Cas9. Cpf1 has different characteristics to Cas9 which some think could give rise to a different range of applications for CRISPR … |
